This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 1985.
Company Filing History:
Years Active: 1985
Title: Joachim Schantl: Innovator in Schistosomicidal Agents
Introduction
Joachim Schantl is a notable inventor based in Innsbruck, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of schistosomicidal agents. His work has implications for treating schistosomiasis, a disease caused by parasitic worms.
Latest Patents
Schantl holds a patent for "Schistosomicidal acridanone hydrazones." This patent describes acridanone derivatives that are useful as schistosomicidal agents. The compounds detailed in the patent include various substituents that enhance their effectiveness in combating schistosomiasis. The patent outlines processes for their preparation and pharmaceutical compositions based on these compounds.
Career Highlights
Throughout his career, Schantl has been associated with Hoffmann-La Roche Inc., a leading global healthcare company. His work at the company has allowed him to focus on innovative solutions in the pharmaceutical industry. Schantl's dedication to research and development has positioned him as a key figure in his field.
Collaborations
Schantl has collaborated with esteemed colleagues such as Hermann Bretschneider and Urs Brombacher. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical agents.
Conclusion
Joachim Schantl's contributions to the field of pharmaceuticals, particularly through his patent on schistosomicidal agents, highlight his innovative spirit and commitment to improving health outcomes. His work continues to influence the development of effective treatments for schistosomiasis.